These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 3136637

  • 1. Long-term efficacy and safety of flecainide for supraventricular tachycardia.
    Neuss H, Schlepper M.
    Am J Cardiol; 1988 Aug 25; 62(6):56D-61D. PubMed ID: 3136637
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 3. Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia.
    Zee-Cheng CS, Kim SS, Ruffy R.
    Am J Cardiol; 1988 Aug 25; 62(6):23D-28D. PubMed ID: 3136631
    [Abstract] [Full Text] [Related]

  • 4. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis.
    van Wijk LM, Crijns HJ, van Gilst WH, Wesseling H, Lie KI.
    Am Heart J; 1989 Feb 25; 117(2):365-9. PubMed ID: 2492738
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
    Hoff PI, Tronstad A, Oie B, Ohm OJ.
    Am J Cardiol; 1988 Sep 15; 62(9):585-9. PubMed ID: 3137798
    [Abstract] [Full Text] [Related]

  • 6. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults.
    Musto B, Cavallaro C, Musto A, D'Onofrio A, Belli A, De Vincentis L.
    Am Heart J; 1992 Jul 15; 124(1):110-5. PubMed ID: 1615792
    [Abstract] [Full Text] [Related]

  • 7. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH, Zabel M.
    Am J Cardiol; 1992 Aug 20; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [Abstract] [Full Text] [Related]

  • 8. Current treatment options for paroxysmal supraventricular tachycardia.
    Mannino MM, Mehta D, Gomes JA.
    Am Heart J; 1994 Feb 20; 127(2):475-80. PubMed ID: 8296727
    [No Abstract] [Full Text] [Related]

  • 9. Flecainide in the Wolff-Parkinson-White syndrome.
    Crozier I.
    Am J Cardiol; 1992 Aug 20; 70(5):26A-32A. PubMed ID: 1509995
    [Abstract] [Full Text] [Related]

  • 10. Long term use of flecainide in patients with supraventricular tachycardia.
    Neuss H.
    Drugs; 1985 Aug 20; 29 Suppl 4():21-5. PubMed ID: 4006776
    [Abstract] [Full Text] [Related]

  • 11. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH.
    Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636
    [Abstract] [Full Text] [Related]

  • 13. Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide.
    Helmy I, Scheinman MM, Herre JM, Sharkey H, Griffin JC.
    J Am Coll Cardiol; 1990 Dec 25; 16(7):1649-55. PubMed ID: 2123908
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing.
    Furlanello F, Guarnerio M, Inama G, Vergara G, Del Greco M, Bertoldi A, Dallago M.
    Am J Cardiol; 1992 Aug 20; 70(5):19A-25A. PubMed ID: 1509994
    [Abstract] [Full Text] [Related]

  • 15. Opposite effects of propafenone and flecainide in a patient with reciprocating supraventricular tachycardia.
    Montenero AS, Natale A, di Bona G, Calvi V, Santarelli P, Manzoli U.
    Cardiologia; 1990 Mar 20; 35(3):253-6. PubMed ID: 2123130
    [Abstract] [Full Text] [Related]

  • 16. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia].
    Song Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec 20; 19(6):361-3, 397. PubMed ID: 1821351
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA, Kuhn RJ, McCaffrey FM.
    Ann Pharmacother; 1997 Oct 20; 31(10):1227-43. PubMed ID: 9337449
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test.
    Calkins H, Sousa J, el-Atassi R, Rosenheck S, de Buitleir M, Kou WH, Kadish AH, Langberg JJ, Morady F.
    N Engl J Med; 1991 Jun 06; 324(23):1612-8. PubMed ID: 2030717
    [Abstract] [Full Text] [Related]

  • 19. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P, Manz M, Schütz R, Lüderitz B.
    Z Kardiol; 1989 Oct 06; 78(10):654-60. PubMed ID: 2686252
    [Abstract] [Full Text] [Related]

  • 20. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V, Mewis C, Mayer F, Seipel L.
    Z Kardiol; 1990 Oct 06; 79(10):725-31. PubMed ID: 2087860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.